Equillium Shares Are Trading Lower After the Company Announced Ono Pharmaceutical Has Made the Business Decision to Allow the Expiration of Its Option to Acquire Equillium's Rights to Itolizumab
Equillium Shares Are Trading Lower After the Company Announced Ono Pharmaceutical Has Made the Business Decision to Allow the Expiration of Its Option to Acquire Equillium's Rights to Itolizumab
Equillium股價下跌，因爲該公司宣佈Ono藥品已經做出業務決定，允許其收購Equillium對Itolizumab的權利期權到期。
Equillium Shares Are Trading Lower After the Company Announced Ono Pharmaceutical Has Made the Business Decision to Allow the Expiration of Its Option to Acquire Equillium's Rights to Itolizumab
Equillium股價下跌，因爲該公司宣佈Ono藥品已經做出業務決定，允許其收購Equillium對Itolizumab的權利期權到期。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間